About us
- >
- About us >
- Information >
- Announcement
2024-10-11
EB Announces Exclusive Licensing AgreementwithPBI Portugal Unipessoal Lda.,a wholly owned subsidiary of the German group Pharma Bavaria International
Energenesis Biomedical CO., LTD has entered into an exclusive licensing agreement with PBI Portugal Unipessoal Lda., a wholly owned subsidiary of the renowned German pharmaceutical group, PBI. The agreement grants PBI thecommercial rights in Portugal and the Middle East for the use of ENERGI-F703DFU in the treatment of diabetic foot ulcers.The markets in Africa and Central America will be phased in based on development milestones, as agreed upon by both parties.